Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial

Overview of attention for article published in Trials, March 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,233 followers.

Comparing doses of bevacizumab for neovascular macular degeneration: new protocol in #Trials citing #ISRCTN - http://t.co/qpnoY3L0g5

Reply Repost Favourite